GLOBAL MAP DATA DICTIONARY #139.5 -- SURGERY TRANSPLANT ASSESSMENTS FILE 6/27/25 PAGE 1
STORED IN ^SRT( *** NO DATA STORED YET *** SITE: WWW.BMIRWIN.COM UCI: VISTA,VISTA (VERSION 3.0)
-----------------------------------------------------------------------------------------------------------------------------------
This file contains the organ transplant procedures performed within VHA facilities, as well as outside the VHA.
CROSS
REFERENCED BY: DATE OF TRANSPLANT(AC), DATE OF TRANSPLANT(ADT), DATE OF LAST TRANSMISSION(AT), PATIENT(B)
INDEXED BY: WARM ISCHEMIA TIME FOR ORGAN & COLD ISCHEMIA TIME FOR ORGAN (AD), VACO ID & PATIENT (AE), TRANSPLANT TYPE &
ASSESSMENT STATUS & PATIENT (AF), DONOR DATE OF BIRTH (AGE)
^SRT(D0,0)= (#.01) PATIENT [1P:2] ^ (#1) DATE OF TRANSPLANT [2D] ^ (#2) SURGERY CASE [3P:130] ^ (#4) RECIPIENT HEIGHT [4F] ^ (#5)
==>RECIPIENT WEIGHT [5F] ^ (#167) PA SYSTOLIC PRESSURE [6F] ^ (#168) PAW MEAN PRESSURE [7F] ^ (#58) UNOS STATUS AT TIME
==>OF LISTING [8S] ^ (#9) RECIPIENT IVIG [9S] ^ (#10) RECIPIENT ABO BLOOD TYPE [10S] ^ (#11) DATE PLACED ON WAITING LIST
==>[11D] ^ (#12) RECIPIENT CMV [12S] ^ (#13) RECIPIENT HLA-A TYPING [13F] ^ (#14) RECIPIENT HLA-B TYPING [14F] ^ (#15)
==>RECIPIENT HLA-C TYPING [15F] ^ (#16) RECIPIENT HLA-BW TYPING [16F] ^ (#17) RECIPIENT HLA-DR TYPING [17F] ^ (#18)
==>RECIPIENT HLA-DQ TYPING [18F] ^ (#50) LAS SCORE AT LISTING [19N] ^ (#51) LAS SCORE AT TRANSPLANT [20N] ^ (#52) MELD
==>SCORE AT LISTING [21N] ^ (#53) BIOLOGIC MELD SCORE AT LISTING [22N] ^ (#54) MELD SCORE AT TRANSPLANT [23N] ^
^SRT(D0,.01)= (#187) DATE STARTED DIALYSIS [1F] ^ (#197) PLASMAPHERESIS [2S] ^ (#143) PRA AT LISTING [3N] ^ (#144) PRA AT
==>TRANSPLANT [4N] ^ (#163) PVR BEFORE VASODILATION [5N] ^ (#164) PVR AFTER VASODILATION [6N] ^ (#165) LVEF% [7N] ^
==>(#166) PRA% [8N] ^ (#57) UNOS STATUS AT TIME OF TRANSP [9S] ^ (#55) BIOLOGIC MELD SCORE AT TRANSP [10N] ^ (#3)
==>VACO ID [11N] ^
^SRT(D0,.02)= (#19) TRANSPLANT COMMENTS [1F] ^
^SRT(D0,.1)= (#20) ACETAMINOPHEN TOXICITY [1S] ^ (#21) ACUTE LIVER FAILURE [2S] ^ (#22) LUNG CANCER [3S] ^ (#23) ALCOHOLIC
==>CIRRHOSIS [4S] ^ (#24) ALPHA 1 ANTI-TRYPSIN DEF [5S] ^ (#25) BRONCHIECTASIS [6S] ^ (#26) GLOMERULAR
==>SCLEROSIS/NEPHRITIS [7S] ^ (#27) GRAFT FAILURE [8S] ^ (#28) HBV CIRRHOSIS (HEPATITIS B) [9S] ^ (#29) HCC
==>(HEPATOCELLULAR CA) [10S] ^ (#30) HCV CIRRHOSIS (HEPATITIS C) [11S] ^ (#128) EMPHYSEMA [12S] ^ (#32) INTERSTITIAL
==>LUNG DISEASE [13S] ^ (#33) MEMBRANOUS NEPHROPATHY [14S] ^ (#34) METABOLIC [15S] ^ (#35) NASH [16S] ^ (#95) IGA
==>NEPHROPATHY [17S] ^ (#37) POLYCYSTIC DISEASE [18S] ^ (#38) PRIMARY BILIARY CHOLANGITIS [19S] ^ (#39) PRIMARY
==>SCLEROSING CHOLANGITIS [20S] ^ (#40) PULMONARY FIBROSIS [21S] ^ (#41) PULMONARY HYPERTENSION [22S] ^ (#42) RENAL
==>CANCER [23S] ^ (#43) SARCOIDOSIS [24S] ^ (#129) OTHER DIAGNOSIS [25F] ^ (#47) BILIARY STRICTURE [26S] ^ (#155)
==>DILATED CARDIOMYOPATHY [27S] ^
^SRT(D0,.11)= (#156) CORONARY ARTERY DISEASE [1S] ^ (#157) ISCHEMIC CARDIOMYOPATHY [2S] ^ (#158) ALCOHOLIC CARDIOMYOPATHY [3S] ^
==>(#96) CALCINEURIN INHIBITOR TOXICITY [4S] ^ (#159) VALVULAR CARDIOMYOPATHY [5S] ^ (#160) IDIOPATHIC CARDIOMYOPATHY
==>[6S] ^ (#161) VIRAL CARDIOMYOPATHY [7S] ^ (#162) PERIPARTUM CARDIOMYOPATHY [8S] ^ (#97) LITHIUM TOXICITY [9S] ^
==>(#98) OBSTRUCTIVE UROPATHY FROM BPH [10S] ^ (#99) AUTOIMMUNE HEPATITIS [11S] ^ (#100) CRYPTOGENIC CIRRHOSIS [12S] ^
==>(#101) CHRONIC REJECTION [13S] ^ (#102) HEPATIC ARTERY THROMBOSIS [14S] ^ (#112) OTHER CARDIOMYOPATHY [15F] ^
==>(#105) PRIMARY NON-FUNCTION [16S] ^ (#106) SECOND SCLEROSING CHOLANGITIS [17S] ^ (#107) TOXIC EXPOSURE [18S] ^
==>(#94) REJECTION [19S] ^ (#56) BILE LEAK [20S] ^ (#111) PORTAL VEIN THROMBOSIS [21S] ^ (#120) PSYCHOSIS [22S] ^
==>(#127) SEIZURES [23S] ^
^SRT(D0,.5)= (#59) DIABETIC RETINOPATHY [1S] ^ (#60) DIABETIC NEUROPATHY [2S] ^ (#61) CARDIAC DISEASE [3S] ^ (#62) INOTROPE
==>DEPENDENT PRE-TRANSP [4S] ^ (#74) PULMONARY HYPER/ELEVATED PAP [5S] ^ (#75) LIVER DISEASE [6S] ^ (#76) COPD [7S] ^
==>(#108) HIV POSITIVE [8S] ^ (#78) PORTO PULMONARY HYPERTENSION [9S] ^ (#79) BLEEDING ESOPH/GASTRIC VARICES [10S] ^
==>(#80) PRE-TRANSPLANT MALIGNANCY [11S] ^ (#81) PRE-TRANSPLANT SKIN MALIGNANCY [12S] ^ (#82) OTHER PRE-TRANS
==>MALIGNANCY [13S] ^ (#83) RECIPIENT SUBSTANCE ABUSE [14S] ^ (#84) ACTIVE INFECTION FOR PSC [15S] ^ (#115) INFECTION
==>REQ ANTIBIOTICS [16S] ^ (#86) ACUTE/CHRONIC ENCEPHALOPATHY [17S] ^ (#131) PREOP FUNCTIONAL HEALTH STATUS [18S] ^
==>(#88) HISTORY OF ASCITES [19S] ^ (#109) POST-TX PROPHYLAXIS - CMV [20S] ^ (#90) NON-COMPLIANCE (MED AND DIET) [21S]
==>^ (#91) ON METHADONE [22S] ^ (#92) POST-TX PROPHYLAXIS - TB [23S] ^ ^ (#132) PERIPHERAL VASCULAR DISEASE [25S] ^
^SRT(D0,.55)= (#110) POST-TX PROPHYLAXIS - PCP [1S] ^ (#71) ELEVATED PAP [2S] ^ (#113) LUNG DISEASE [3S] ^ (#114) RENAL
==>IMPAIRMENT [4S] ^ (#145) HYPERTENSION REQUIRING MEDS [5S] ^ (#146) TRANSFUSION >4 RBC UNITS [6S] ^ (#147) *DIABETES
==>MELLITUS [7S] ^ (#149) AMIODARONE USE [8S] ^ (#150) HEPARIN SENSITIVITY [9S] ^ (#151) HYPERLIPIDEMIA HISTORY [10S]
==>^ (#152) VENTRICULAR TACHYCARDIA [11S] ^ (#153) PRIOR BLOOD TRANSFUSION [12S] ^ (#154) CREATININE ON TRANSPLANT DAY
==>[13N] ^ (#169) FEV1 [14F] ^ (#171) *CURRENT SMOKER [15S] ^ (#172) PRIOR MI [16S] ^ (#173) NUM OF PRIOR HEART
==>SURGERIES [17S] ^ (#174) *CEREBRAL VASCULAR DISEASE [18S] ^ (#175) CONGESTIVE HEART FAILURE [19S] ^ (#176) IV NTG
==>WITHIN 48 HOURS [20S] ^ (#177) CURRENT DIGOXIN USE [21S] ^ (#178) CURRENT DIURETIC USE [22S] ^ (#179) PREOP
==>CIRCULATORY DEVICE [23S] ^ (#198) TOBACCO USE [24S] ^ (#199) TOBACCO USE TIMEFRAME [25S] ^ (#200) DIABETES MELLITUS
==>CHRONIC [26S] ^ (#201) DIABETES MELLITUS PREOP MGMT [27S] ^ (#202) CVD REPAIR/OBSTRUCTION [28S] ^ (#203) HISTORY OF
==>CVD [29S] ^
^SRT(D0,1)= (#70) DONOR DATE OF BIRTH [1D] ^ (#31) DONOR HEIGHT [2F] ^ (#36) DONOR WEIGHT [3F] ^ (#77) DONOR SUBSTANCE ABUSE [4S]
==>^ (#45) DONOR GENDER [5S] ^ (#46) DONOR AGE [6F] ^ ^ (#48) DONOR ABO BLOOD TYPE [8S] ^ (#49) DONOR CMV [9S] ^ (#64)
==>DONOR HLA-A TYPING [10F] ^ (#65) DONOR HLA-B TYPING [11F] ^ (#66) DONOR HLA-C TYPING [12F] ^ (#67) DONOR HLA-BW
==>TYPING [13F] ^ (#72) DONOR HLA-DQ TYPING [14F] ^ (#73) DONOR HLA-DR TYPING [15F] ^
^SRT(D0,3)= (#69) DECEASED DONOR [1S] ^ (#103) LIVING DONOR [2S] ^ (#104) DONOR WITH MALIGNANCY [3S] ^ (#85) WARM ISCHEMIA TIME
==>FOR ORGAN [4N] ^ (#87) COLD ISCHEMIA TIME FOR ORGAN [5N] ^ (#89) TOTAL ISCHEMIA TIME FOR ORGAN [6N] ^ (#68)
==>CROSSMATCH D/R [7S] ^
^SRT(D0,8)= (#63) DIVISION [1P:4] ^
^SRT(D0,10)= (#116) BLEEDING/TRANSFUSIONS [1S] ^ (#117) PNEUMONIA [2S] ^ (#118) ON VENTILATOR >48 HOURS [3S] ^ (#119) CARDIAC
==>ARREST REQ CPR [4S] ^ (#130) NEW MECHANICAL CIRCULATORY [5S] ^ (#121) STROKE/CVA [6S] ^ (#122) COMA > 24 HOURS
==>POSTOP [7S] ^ (#123) SUPERFICIAL INCISIONAL SSI [8S] ^ (#124) DEEP INCISIONAL SSI [9S] ^ (#125) SYSTEMIC SEPSIS
==>[10S] ^ (#126) RETURN TO SURGERY W/I 30 DAYS [11S] ^ (#148) REOPERATION FOR BLEEDING [12S] ^ (#133) GRAFT FAILURE
==>DATE [13F] ^ (#189) TRACHEOSTOMY [14S] ^ (#190) MEDIASTINITIS [15S] ^ (#191) RENAL FAILURE REQ. DIALYSIS [16S] ^
==>(#192) PERIOPERATIVE MI [17S] ^ (#193) OPERATIVE DEATH [18S] ^ (#170) DATE OF DEATH [19F] ^
^SRT(D0,11)= (#134) PANCREAS [1S] ^ (#135) GLUCOSE AT TIME OF LISTING [2F] ^ (#136) C-PEPTIDE AT TIME OF LISTING [3F] ^ (#137)
==>PANCREATIC DUCT ANASTOMOSIS [4S] ^ (#138) GLUCOSE POST TRANSPLANT [5F] ^ (#139) AMYLASE POST TRANSPLANT [6F] ^
==>(#140) LIPASE POST TRANSPLANT [7F] ^ (#141) INSULIN REQ POST TRANSPLANT [8S] ^ (#142) ORAL HYPOGLYCEMICS/POST TRANS
==>[9S] ^
^SRT(D0,44,0)=^139.544SA^^ (#44) DONOR RACE
^SRT(D0,44,D1,0)= (#.01) DONOR RACE [1S] ^
^SRT(D0,RA)= (#181) ASSESSMENT STATUS [1S] ^ (#182) TRANSPLANT TYPE [2S] ^ (#183) RE-TRANSMISSION [3S] ^ (#184) DATE TRANSMITTED
==>[4D] ^ (#185) VA/NON VA INDICATOR [5S] ^ ^ ^ (#188) DATE OF LAST TRANSMISSION [8D] ^
INPUT TEMPLATE(S):
PRINT TEMPLATE(S):
SORT TEMPLATE(S):
FORM(S)/BLOCK(S):